| High-level and high-throughput recombinant protein production by transient transfection of suspension-growing human 293-EBNA1 cells Y Durocher, S Perret, A Kamen Nucleic acids research 30 (2), e9-e9, 2002 | 1369 | 2002 |
| Persistence of serum and saliva antibody responses to SARS-CoV-2 spike antigens in COVID-19 patients B Isho, KT Abe, M Zuo, AJ Jamal, B Rathod, JH Wang, Z Li, G Chao, ... Science immunology 5 (52), eabe5511, 2020 | 872 | 2020 |
| Expression systems for therapeutic glycoprotein production Y Durocher, M Butler Current opinion in biotechnology 20 (6), 700-707, 2009 | 521 | 2009 |
| MANF: a new mesencephalic, astrocyte-derived neurotrophic factor with selectivity for dopaminergic neurons PS Petrova, A Raibekas, J Pevsner, N Vigo, M Anafi, MK Moore, ... Journal of Molecular Neuroscience 20, 173-187, 2003 | 438 | 2003 |
| Therapeutic glycoprotein production in mammalian cells ME Lalonde, Y Durocher Journal of biotechnology 251, 128-140, 2017 | 383 | 2017 |
| Nuclear localization of prostaglandin E2 receptors M Bhattacharya, KG Peri, G Almazan, A Ribeiro-da-Silva, H Shichi, ... Proceedings of the National Academy of Sciences 95 (26), 15792-15797, 1998 | 321 | 1998 |
| Large-scale transfection of mammalian cells for the fast production of recombinant protein PL Pham, A Kamen, Y Durocher Molecular biotechnology 34, 225-237, 2006 | 293 | 2006 |
| Delphinidin, a dietary anthocyanidin, inhibits vascular endothelial growth factor receptor-2 phosphorylation S Lamy, M Blanchette, J Michaud-Levesque, R Lafleur, Y Durocher, ... Carcinogenesis 27 (5), 989-996, 2006 | 210 | 2006 |
| A simple protein-based surrogate neutralization assay for SARS-CoV-2 KT Abe, Z Li, R Samson, P Samavarchi-Tehrani, EJ Valcourt, H Wood, ... JCI insight 5 (19), e142362, 2020 | 206 | 2020 |
| Combined inhibition of PDGF and VEGF receptors by ellagic acid, a dietary-derived phenolic compound L Labrecque, S Lamy, A Chapus, S Mihoubi, Y Durocher, B Cass, ... Carcinogenesis 26 (4), 821-826, 2005 | 200 | 2005 |
| Src-mediated tyrosine phosphorylation of caveolin-1 induces its association with membrane type 1 matrix metalloproteinase L Labrecque, C Nyalendo, S Langlois, Y Durocher, C Roghi, G Murphy, ... Journal of Biological Chemistry 279 (50), 52132-52140, 2004 | 187 | 2004 |
| Development of a scalable process for high‐yield lentiviral vector production by transient transfection of HEK293 suspension cultures S Ansorge, S Lanthier, J Transfiguracion, Y Durocher, O Henry, A Kamen The Journal of Gene Medicine: A cross‐disciplinary journal for research on …, 2009 | 183 | 2009 |
| Production of lentiviral vectors by large‐scale transient transfection of suspension cultures and affinity chromatography purification MM Segura, A Garnier, Y Durocher, H Coelho, A Kamen Biotechnology and bioengineering 98 (4), 789-799, 2007 | 182 | 2007 |
| Inducible packaging cells for large-scale production of lentiviral vectors in serum-free suspension culture S Broussau, N Jabbour, G Lachapelle, Y Durocher, R Tom, ... Molecular Therapy 16 (3), 500-507, 2008 | 181 | 2008 |
| Large‐scale transient transfection of serum‐free suspension‐growing HEK293 EBNA1 cells: Peptone additives improve cell growth and transfection efficiency PL Pham, S Perret, HC Doan, B Cass, G St‐Laurent, A Kamen, ... Biotechnology and bioengineering 84 (3), 332-342, 2003 | 174 | 2003 |
| Improving biophysical properties of a bispecific antibody scaffold to aid developability: quality by molecular design TS Von Kreudenstein, E Escobar-Carbrera, PI Lario, I D’Angelo, K Brault, ... MAbs 5 (5), 646-654, 2013 | 167 | 2013 |
| Differential tumor-targeting abilities of three single-domain antibody formats A Bell, ZJ Wang, M Arbabi-Ghahroudi, TA Chang, Y Durocher, U Trojahn, ... Cancer letters 289 (1), 81-90, 2010 | 158 | 2010 |
| Transient gene expression in HEK293 cells: peptone addition posttransfection improves recombinant protein synthesis PL Pham, S Perret, B Cass, E Carpentier, G St‐Laurent, L Bisson, ... Biotechnology and bioengineering 90 (3), 332-344, 2005 | 158 | 2005 |
| Glioblastoma-secreted factors induce IGFBP7 and angiogenesis by modulating Smad-2-dependent TGF-β signaling A Pen, MJ Moreno, Y Durocher, P Deb-Rinker, DB Stanimirovic Oncogene 27 (54), 6834-6844, 2008 | 143 | 2008 |
| Antiperlecan antibodies are novel accelerators of immune-mediated vascular injury H Cardinal, M Dieudé, N Brassard, S Qi, N Patey, M Soulez, D Beillevaire, ... American Journal of Transplantation 13 (4), 861-874, 2013 | 142 | 2013 |
Gregory De CrescenzoChemical / Biomedical Engineering Polytechnique MontréalПідтверджена електронна адреса в polymtl.ca
